Skip to main content
Clinical Trials/NCT04997642
NCT04997642RecruitingNot Applicable

Parkinson's Disease and Movement Disorders Clinical Database

University of Pennsylvania1 site in 1 country250 target enrollmentStarted: September 30, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
250
Locations
1
Primary Endpoint
Genetic and Neurobiological factors

Study Overview

Brief Summary

The research database contains demographic and family history information, longitudinal information on the clinical symptoms, neuropsychological profile and treatments, stored biological samples, and brain images of patients with Parkinson's disease and related disorders receiving care at the Parkinson's disease and Movement Disorders Center and the Hospital of the University of Pennsylvania.

Detailed Description

The research database contains demographic and family history information, longitudinal information on the clinical symptoms, neuropsychological profile and treatments, stored biological samples, and brain images of patients with Parkinson's disease and related disorders receiving care at the Parkinson's disease and Movement Disorders Center (PDMDC) and the Hospital of the University of Pennsylvania.

The purpose of the research database is to have a comprehensive source of data that can be used for educational, research and patient care projects at the PDMDC. These data may be used for any study examining the relationship between treatment and clinical symptoms of patients with PD and related disorders. The main uses of the data are to:

  • Determine the long term effects of Parkinson's disease and related conditions, including predictors of its motor and non-motor symptoms
  • Identify genetic and other neurobiological factors related to the risk of developing Parkinson's disease and related disorders and their course
  • Improve our understanding of how best to identify, diagnose, and manage motor and non-motor symptoms of Parkinson's disease and related conditions Evaluate biological markers of disease or response to therapy
  • Identify patients who may be candidates for participation in trials of new medications.
  • Identify patients who may be interested in participating in educational or developmental activities

Participants are seen annually for the first 4 years, biennially thereafter. The participants continue in the study until study end, withdrawal, or death on study.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Any person who receives medical care for the diagnosis of Parkinson's disease with mild cognitive impairment (MCI) or dementia may be eligible to participate in the research database. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments.

Exclusion Criteria

  • Absence of Parkinson's disease diagnosis. There are no limitations for database participation based on age, disease severity or presence of cognitive impairments, as long as the person is able to complete the research assessments.

Outcomes

Primary Outcomes

Genetic and Neurobiological factors

Time Frame: 5 years

Identify genetic and other neurobiological factors related to the risk of developing Parkinson's disease and related disorders and their course

Long term effects of Parkinson's disease

Time Frame: 5 years

Determine the long term effects of Parkinson's disease and related conditions, including predictors of its motor and non-motor symptoms

Secondary Outcomes

  • Identification and Diagnosis of Parkinson's disease(5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniel Weintraub

Professor of Psychiatry and Neurology

University of Pennsylvania

Study Sites (1)

Loading locations...

Similar Trials

Parkinson's Disease and Movement Disorders... | Clinical Trial